0.09 (-94.40%)
As of Apr 12, 2023
Source:
We are a commercial-stage drug delivery platform technology company focused on improving how and where APIs are absorbed in the GI tract via our clinically validated and patent protected PLxGuard™ technology. We believe this platform has the potential to improve the absorption of many drugs currently on the market or in development and to reduce the risk of stomach injury associated with certain drugs.
Country | United States |
Headquarters | sparta, new jersey |
Phone Number | (713) 842-1249 |
Industry | manufacturing |
CEO | Natasha Giordano |
Website |